Van Biesen Wim
Renal Division, Ghent University Hospital, Ghent, Belgium.
Nephrol Dial Transplant. 2017 Mar 1;32(3):414-417. doi: 10.1093/ndt/gfx017.
Acute kidney injury (AKI) is an important health-care problem. Over the last decades, many innovative therapies and diagnostic approaches have been tried; however, none of these has been able to confirm consistently that they lead to improved outcomes. Much focus has been placed on intensive care unit (ICU)-associated AKI, whereas the bulk of AKI still concerns patients not in the ICU. Involvement of nephrologists in the care of AKI patients is necessary to further improve outcomes. It is unclear whether new technologies, such as biomarkers, are helpful and could replace nephrology consultation.
急性肾损伤（AKI）是一个重要的医疗保健问题。在过去几十年中，人们尝试了许多创新疗法和诊断方法；然而，这些方法都未能始终如一地证实它们能带来更好的治疗效果。人们将大量注意力放在了与重症监护病房（ICU）相关的AKI上，而大部分AKI患者仍是非ICU患者。肾病科医生参与AKI患者的护理对于进一步改善治疗效果是必要的。目前尚不清楚诸如生物标志物等新技术是否有用，以及能否取代肾病科会诊。
